CERS

Cerus Stock Price

5.96
-0.24 (-3.87%)
Upgrade to Real-Time
Regular Market
5.96
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Cerus Corp CERS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.24 -3.87% 5.96 13:13:14
Open Price Low Price High Price Close Price Prev Close
6.28 5.89 6.28 6.20
Bid Price Ask Price Spread News
5.95 5.96 0.01 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
13,151 1,567,376 $ 6.07 $ 9,509,350 2,336,180 2.71 - 9.00
Last Trade Time Type Quantity Stock Price Currency
13:13:20 100 $ 5.96 USD

Cerus Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 996.17M 167.14M 163.65M $ 93.77M $ -52.87M -0.52 -18.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Cerus News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CERS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week6.496.66185.516.254,228,487-0.53-8.17%
1 Month7.658.415.516.782,619,569-1.69-22.09%
3 Months7.638.875.517.112,290,644-1.67-21.89%
6 Months5.728.875.156.771,862,3980.244.2%
1 Year5.299.002.716.291,868,8800.6712.67%
3 Years4.809.002.715.931,286,7951.1624.17%
5 Years5.599.001.935.441,185,7030.376.62%

Cerus Description

Cerus Corp is a biomedical products company focused in the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East and selected countries in other regions around the world. The firm continues to operate in only one segment: blood safety and generates revenue from the same.


Your Recent History
NASDAQ
CERS
Cerus
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.